Article info
PDFClinical and epidemiological research
Extended report
Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial
- Correspondence to Dr Diederik De Cock, Department of Rheumatology, UZ Herestraat 49—bus 7003, Leuven 3000, Belgium; diederik.decock{at}med.kuleuven.be
Citation
Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial
Publication history
- Received January 17, 2016
- Revised June 15, 2016
- Accepted June 25, 2016
- First published July 18, 2016.
Online issue publication
February 11, 2021
Article Versions
- Previous version (11 February 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/